{"id":"https://openalex.org/W2989887645","doi":"https://doi.org/10.1038/s41523-019-0139-1","title":"Response to Olaparib in a Patient with Germline BRCA2 Mutation and Breast Cancer Leptomeningeal Carcinomatosis","display_name":"Response to Olaparib in a Patient with Germline BRCA2 Mutation and Breast Cancer Leptomeningeal Carcinomatosis","publication_year":2019,"publication_date":"2019-11-29","ids":{"openalex":"https://openalex.org/W2989887645","doi":"https://doi.org/10.1038/s41523-019-0139-1","mag":"2989887645","pmid":"https://pubmed.ncbi.nlm.nih.gov/31815182","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/6884546"},"language":"en","primary_location":{"id":"doi:10.1038/s41523-019-0139-1","doi":"https://doi.org/10.1038/s41523-019-0139-1","is_oa":true,"landing_page_url":"https://doi.org/10.1038/s41523-019-0139-1","pdf_url":"https://www.nature.com/articles/s41523-019-0139-1.pdf","source":{"id":"https://openalex.org/S4210207747","display_name":"npj Breast Cancer","issn_l":"2374-4677","issn":["2374-4677"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","jufo-1","ki-jl-1","norway-1","oarl","poland-40","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319908","host_organization_name":"Nature Portfolio","host_organization_lineage":["https://openalex.org/P4310319908","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Nature Portfolio","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"npj Breast Cancer","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.nature.com/articles/s41523-019-0139-1.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5068085565","display_name":"Pedro Exman","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Pedro Exman","raw_affiliation_strings":["1Medical Oncology, Dana-Farber Cancer Institute, Boston, MA USA","Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Medical Oncology, Dana-Farber Cancer Institute, Boston, MA USA","institution_ids":["https://openalex.org/I4210117453"]},{"raw_affiliation_string":"Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052478477","display_name":"Robert M. Mallery","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Robert M. Mallery","raw_affiliation_strings":["2Department of Neurology, Brigham and Women's Hospital, Boston, MA USA","Department of Neurology, Brigham and Women's Hospital, Boston, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Department of Neurology, Brigham and Women's Hospital, Boston, MA USA","institution_ids":["https://openalex.org/I1283280774"]},{"raw_affiliation_string":"Department of Neurology, Brigham and Women's Hospital, Boston, MA, USA","institution_ids":["https://openalex.org/I1283280774"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022319770","display_name":"NU Lin","orcid":"https://orcid.org/0000-0003-2263-5413","observed_orcids":["https://orcid.org/0000-0003-2263-5413"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nancy U. Lin","raw_affiliation_strings":["1Medical Oncology, Dana-Farber Cancer Institute, Boston, MA USA","Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Medical Oncology, Dana-Farber Cancer Institute, Boston, MA USA","institution_ids":["https://openalex.org/I4210117453"]},{"raw_affiliation_string":"Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5088801158","display_name":"Heather Anne Parsons","orcid":"https://orcid.org/0000-0001-8178-6612","observed_orcids":["https://orcid.org/0000-0001-8178-6612"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Heather A. Parsons","raw_affiliation_strings":["1Medical Oncology, Dana-Farber Cancer Institute, Boston, MA USA","Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA"],"raw_orcid":"https://orcid.org/0000-0001-8178-6612","affiliations":[{"raw_affiliation_string":"1Medical Oncology, Dana-Farber Cancer Institute, Boston, MA USA","institution_ids":["https://openalex.org/I4210117453"]},{"raw_affiliation_string":"Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA","institution_ids":["https://openalex.org/I4210117453"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5088801158"],"corresponding_institution_ids":["https://openalex.org/I4210117453"],"apc_list":{"value":2990,"currency":"USD","value_usd":2990},"apc_paid":{"value":2990,"currency":"USD","value_usd":2990},"fwci":2.4994,"has_fulltext":true,"cited_by_count":37,"citation_normalized_percentile":{"value":0.91252783,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":94,"max":99},"biblio":{"volume":"5","issue":"1","first_page":"46","last_page":"46"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11914","display_name":"PARP inhibition in cancer therapy","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11914","display_name":"PARP inhibition in cancer therapy","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10769","display_name":"BRCA gene mutations in cancer","score":0.0010000000474974513,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11600","display_name":"Brain Metastases and Treatment","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/olaparib","display_name":"olaparib","score":0.9539999961853027},{"id":"https://openalex.org/keywords/brca2-mutation","display_name":"BRCA2 mutation","score":0.8600000143051147},{"id":"https://openalex.org/keywords/breast-cancer","display_name":"breast cancer","score":0.722000002861023},{"id":"https://openalex.org/keywords/leptomeningeal-metastasis","display_name":"leptomeningeal metastasis","score":0.9919999837875366},{"id":"https://openalex.org/keywords/parp-inhibitors","display_name":"PARP inhibitors","score":0.8560000061988831},{"id":"https://openalex.org/keywords/germline-brca-mutation","display_name":"germline BRCA mutation","score":0.8339999914169312},{"id":"https://openalex.org/keywords/central-nervous-system-metastases","display_name":"central nervous system metastasis","score":0.8539999723434448},{"id":"https://openalex.org/keywords/complete-response","display_name":"complete response","score":0.5519999861717224}],"concepts":[{"id":"https://openalex.org/C2779962180","wikidata":"https://www.wikidata.org/wiki/Q7083106","display_name":"Olaparib","level":5,"score":0.9028652310371399},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.6177727580070496},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6003048419952393},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5780988335609436},{"id":"https://openalex.org/C13514818","wikidata":"https://www.wikidata.org/wiki/Q5552256","display_name":"Germline mutation","level":4,"score":0.5389626026153564},{"id":"https://openalex.org/C109825262","wikidata":"https://www.wikidata.org/wiki/Q1139164","display_name":"Germline","level":3,"score":0.5283882021903992},{"id":"https://openalex.org/C501734568","wikidata":"https://www.wikidata.org/wiki/Q42918","display_name":"Mutation","level":3,"score":0.4342649579048157},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.43408501148223877},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.432917058467865},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.40529242157936096},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.18180206418037415},{"id":"https://openalex.org/C182979987","wikidata":"https://www.wikidata.org/wiki/Q3907241","display_name":"Poly ADP ribose polymerase","level":4,"score":0.10156261920928955},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.09123539924621582},{"id":"https://openalex.org/C82381507","wikidata":"https://www.wikidata.org/wiki/Q416878","display_name":"Polymerase","level":3,"score":0.054282426834106445},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0}],"mesh":[],"locations_count":4,"locations":[{"id":"doi:10.1038/s41523-019-0139-1","doi":"https://doi.org/10.1038/s41523-019-0139-1","is_oa":true,"landing_page_url":"https://doi.org/10.1038/s41523-019-0139-1","pdf_url":"https://www.nature.com/articles/s41523-019-0139-1.pdf","source":{"id":"https://openalex.org/S4210207747","display_name":"npj Breast Cancer","issn_l":"2374-4677","issn":["2374-4677"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","jufo-1","ki-jl-1","norway-1","oarl","poland-40","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319908","host_organization_name":"Nature Portfolio","host_organization_lineage":["https://openalex.org/P4310319908","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Nature Portfolio","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"npj Breast Cancer","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:6884546","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/6884546","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"NPJ Breast Cancer","raw_type":"Text"},{"id":"pmid:31815182","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/31815182","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"NPJ breast cancer","raw_type":"Case Reports"},{"id":"pmh:oai:doaj.org/article:63c8c37b786441539993591465fdd082","doi":null,"is_oa":false,"landing_page_url":"https://doaj.org/article/63c8c37b786441539993591465fdd082","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"npj Breast Cancer, Vol 5, Iss 1, Pp 1-5 (2019)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1038/s41523-019-0139-1","doi":"https://doi.org/10.1038/s41523-019-0139-1","is_oa":true,"landing_page_url":"https://doi.org/10.1038/s41523-019-0139-1","pdf_url":"https://www.nature.com/articles/s41523-019-0139-1.pdf","source":{"id":"https://openalex.org/S4210207747","display_name":"npj Breast Cancer","issn_l":"2374-4677","issn":["2374-4677"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","jufo-1","ki-jl-1","norway-1","oarl","poland-40","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319908","host_organization_name":"Nature Portfolio","host_organization_lineage":["https://openalex.org/P4310319908","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Nature Portfolio","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"npj Breast Cancer","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[{"display_name":"Case Report","id":"https://openalex.org/study-designs/case-report"}],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2989887645.pdf","grobid_xml":"https://content.openalex.org/works/W2989887645.grobid-xml"},"referenced_works_count":33,"referenced_works":["https://openalex.org/W21584975","https://openalex.org/W1528402523","https://openalex.org/W1937707643","https://openalex.org/W2000002381","https://openalex.org/W2000470201","https://openalex.org/W2006145937","https://openalex.org/W2013669698","https://openalex.org/W2025314648","https://openalex.org/W2039373864","https://openalex.org/W2042702856","https://openalex.org/W2056423296","https://openalex.org/W2081302423","https://openalex.org/W2082334960","https://openalex.org/W2095605943","https://openalex.org/W2110017381","https://openalex.org/W2111437716","https://openalex.org/W2136558504","https://openalex.org/W2161499840","https://openalex.org/W2162618795","https://openalex.org/W2174658047","https://openalex.org/W2536596154","https://openalex.org/W2607562158","https://openalex.org/W2621271973","https://openalex.org/W2664130335","https://openalex.org/W2886187051","https://openalex.org/W2886477543","https://openalex.org/W2954749227","https://openalex.org/W2978713168","https://openalex.org/W2982520676","https://openalex.org/W3093265161","https://openalex.org/W4211086468","https://openalex.org/W4247315025","https://openalex.org/W6939433104"],"related_works":["https://openalex.org/W4391332262","https://openalex.org/W6939433104","https://openalex.org/W4400522869","https://openalex.org/W2536596154","https://openalex.org/W3019010909","https://openalex.org/W4408678926","https://openalex.org/W2982453586","https://openalex.org/W4283211017","https://openalex.org/W4281981354","https://openalex.org/W3189061716"],"abstract_inverted_index":{"Leptomeningeal":[0],"carcinomatosis":[1],"(LC)":[2],"is":[3],"a":[4,76,91,94],"devastating":[5],"complication":[6],"of":[7,80,93],"metastatic":[8],"cancer":[9,99],"that":[10],"disproportionately":[11],"affects":[12],"patients":[13,47,58,126],"with":[14,20,48,59,96,106,112,127],"advanced":[15],"breast":[16,50,98],"cancer.":[17],"Moreover,":[18],"those":[19],"BRCA1/2-mutated":[21,49],"disease":[22,129],"more":[23],"often":[24,35],"experience":[25],"leptomeningeal":[26],"metastasis.":[27],"Treatment":[28],"options":[29],"for":[30,46,125],"LC":[31],"are":[32,72],"limited":[33],"and":[34,51,100,130,132],"include":[36],"significant":[37],"toxicities.":[38],"PARP":[39,114,117],"inhibitors":[40,118],"offer":[41],"an":[42,121],"important":[43,122],"potential":[44],"treatment":[45,111,123],"ovarian":[52],"cancers,":[53],"but":[54],"clinical":[55],"studies":[56],"excluded":[57],"central":[60],"nervous":[61],"system":[62],"(CNS)":[63],"metastases,":[64],"including":[65],"LC.":[66],"Efficacy":[67],"data":[68],"in":[69,82,103],"this":[70],"area":[71],"therefore":[73],"limited,":[74],"although":[75],"phase":[77],"I":[78],"study":[79],"olaparib":[81],"glioblastoma":[83],"did":[84],"show":[85],"CNS":[86],"penetration.":[87],"Here":[88],"we":[89],"report":[90],"case":[92],"patient":[95],"BRCA2-mutated":[97],"solitary":[101],"recurrence":[102],"the":[104,113],"leptomeninges":[105],"ongoing":[107],"complete":[108],"response":[109],"to":[110],"inhibitor":[115],"olaparib.":[116],"may":[119],"be":[120],"option":[124],"BRCA-mutated":[128],"LC,":[131],"warrant":[133],"further":[134],"study.":[135]},"counts_by_year":[{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":7},{"year":2023,"cited_by_count":6},{"year":2022,"cited_by_count":14},{"year":2021,"cited_by_count":5},{"year":2020,"cited_by_count":3}],"updated_date":"2026-11-03T10:50:19.383937","created_date":"2019-12-05T00:00:00"}
